Global Hepatitis A and B Vaccine Market Research Report 2024(Status and Outlook)
Report Overview:
The hepatitis A and hepatitis B vaccinescan be given separately or as a combination vaccine. All the shots in the series are needed for long-term protection. The full series of the hepatitis A and hepatitis B vaccines require 2-3 shots, depending on the type of vaccine.
The Global Hepatitis A and B Vaccine Market Size was estimated at USD 1834.43 million in 2023 and is projected to reach USD 2041.68 million by 2029, exhibiting a CAGR of 1.80% during the forecast period.
This report provides a deep insight into the global Hepatitis A and B Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Hepatitis A and B Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Hepatitis A and B Vaccine market in any manner.
Global Hepatitis A and B Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
KM Biologics
IMBCAMS
Convac
NCPC
Bio Kangtai
Dynavax
Hissen
LG Life Sciences
Serum Institute
Market Segmentation (by Type)
Hepatitis A Vaccination
Hepatitis B Vaccination
Market Segmentation (by Application)
Government Institution
Private Sector
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Hepatitis A and B Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
The hepatitis A and hepatitis B vaccinescan be given separately or as a combination vaccine. All the shots in the series are needed for long-term protection. The full series of the hepatitis A and hepatitis B vaccines require 2-3 shots, depending on the type of vaccine.
The Global Hepatitis A and B Vaccine Market Size was estimated at USD 1834.43 million in 2023 and is projected to reach USD 2041.68 million by 2029, exhibiting a CAGR of 1.80% during the forecast period.
This report provides a deep insight into the global Hepatitis A and B Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Hepatitis A and B Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Hepatitis A and B Vaccine market in any manner.
Global Hepatitis A and B Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
KM Biologics
IMBCAMS
Convac
NCPC
Bio Kangtai
Dynavax
Hissen
LG Life Sciences
Serum Institute
Market Segmentation (by Type)
Hepatitis A Vaccination
Hepatitis B Vaccination
Market Segmentation (by Application)
Government Institution
Private Sector
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Hepatitis A and B Vaccine Market
- Overview of the regional outlook of the Hepatitis A and B Vaccine Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Hepatitis A and B Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Hepatitis A and B Vaccine
1.2 Key Market Segments
1.2.1 Hepatitis A and B Vaccine Segment by Type
1.2.2 Hepatitis A and B Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HEPATITIS A AND B VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Hepatitis A and B Vaccine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Hepatitis A and B Vaccine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HEPATITIS A AND B VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Global Hepatitis A and B Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Hepatitis A and B Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Hepatitis A and B Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Hepatitis A and B Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Hepatitis A and B Vaccine Sales Sites, Area Served, Product Type
3.6 Hepatitis A and B Vaccine Market Competitive Situation and Trends
3.6.1 Hepatitis A and B Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Hepatitis A and B Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 HEPATITIS A AND B VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Hepatitis A and B Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HEPATITIS A AND B VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 HEPATITIS A AND B VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Hepatitis A and B Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Hepatitis A and B Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Hepatitis A and B Vaccine Price by Type (2019-2024)
7 HEPATITIS A AND B VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Hepatitis A and B Vaccine Market Sales by Application (2019-2024)
7.3 Global Hepatitis A and B Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Hepatitis A and B Vaccine Sales Growth Rate by Application (2019-2024)
8 HEPATITIS A AND B VACCINE MARKET SEGMENTATION BY REGION
8.1 Global Hepatitis A and B Vaccine Sales by Region
8.1.1 Global Hepatitis A and B Vaccine Sales by Region
8.1.2 Global Hepatitis A and B Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Hepatitis A and B Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Hepatitis A and B Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Hepatitis A and B Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Hepatitis A and B Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Hepatitis A and B Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 GSK
9.1.1 GSK Hepatitis A and B Vaccine Basic Information
9.1.2 GSK Hepatitis A and B Vaccine Product Overview
9.1.3 GSK Hepatitis A and B Vaccine Product Market Performance
9.1.4 GSK Business Overview
9.1.5 GSK Hepatitis A and B Vaccine SWOT Analysis
9.1.6 GSK Recent Developments
9.2 Merck
9.2.1 Merck Hepatitis A and B Vaccine Basic Information
9.2.2 Merck Hepatitis A and B Vaccine Product Overview
9.2.3 Merck Hepatitis A and B Vaccine Product Market Performance
9.2.4 Merck Business Overview
9.2.5 Merck Hepatitis A and B Vaccine SWOT Analysis
9.2.6 Merck Recent Developments
9.3 Sanofi
9.3.1 Sanofi Hepatitis A and B Vaccine Basic Information
9.3.2 Sanofi Hepatitis A and B Vaccine Product Overview
9.3.3 Sanofi Hepatitis A and B Vaccine Product Market Performance
9.3.4 Sanofi Hepatitis A and B Vaccine SWOT Analysis
9.3.5 Sanofi Business Overview
9.3.6 Sanofi Recent Developments
9.4 Sinovac
9.4.1 Sinovac Hepatitis A and B Vaccine Basic Information
9.4.2 Sinovac Hepatitis A and B Vaccine Product Overview
9.4.3 Sinovac Hepatitis A and B Vaccine Product Market Performance
9.4.4 Sinovac Business Overview
9.4.5 Sinovac Recent Developments
9.5 Zhejiang Pukang
9.5.1 Zhejiang Pukang Hepatitis A and B Vaccine Basic Information
9.5.2 Zhejiang Pukang Hepatitis A and B Vaccine Product Overview
9.5.3 Zhejiang Pukang Hepatitis A and B Vaccine Product Market Performance
9.5.4 Zhejiang Pukang Business Overview
9.5.5 Zhejiang Pukang Recent Developments
9.6 Changchun Institute of Biological
9.6.1 Changchun Institute of Biological Hepatitis A and B Vaccine Basic Information
9.6.2 Changchun Institute of Biological Hepatitis A and B Vaccine Product Overview
9.6.3 Changchun Institute of Biological Hepatitis A and B Vaccine Product Market Performance
9.6.4 Changchun Institute of Biological Business Overview
9.6.5 Changchun Institute of Biological Recent Developments
9.7 KM Biologics
9.7.1 KM Biologics Hepatitis A and B Vaccine Basic Information
9.7.2 KM Biologics Hepatitis A and B Vaccine Product Overview
9.7.3 KM Biologics Hepatitis A and B Vaccine Product Market Performance
9.7.4 KM Biologics Business Overview
9.7.5 KM Biologics Recent Developments
9.8 IMBCAMS
9.8.1 IMBCAMS Hepatitis A and B Vaccine Basic Information
9.8.2 IMBCAMS Hepatitis A and B Vaccine Product Overview
9.8.3 IMBCAMS Hepatitis A and B Vaccine Product Market Performance
9.8.4 IMBCAMS Business Overview
9.8.5 IMBCAMS Recent Developments
9.9 Convac
9.9.1 Convac Hepatitis A and B Vaccine Basic Information
9.9.2 Convac Hepatitis A and B Vaccine Product Overview
9.9.3 Convac Hepatitis A and B Vaccine Product Market Performance
9.9.4 Convac Business Overview
9.9.5 Convac Recent Developments
9.10 NCPC
9.10.1 NCPC Hepatitis A and B Vaccine Basic Information
9.10.2 NCPC Hepatitis A and B Vaccine Product Overview
9.10.3 NCPC Hepatitis A and B Vaccine Product Market Performance
9.10.4 NCPC Business Overview
9.10.5 NCPC Recent Developments
9.11 Bio Kangtai
9.11.1 Bio Kangtai Hepatitis A and B Vaccine Basic Information
9.11.2 Bio Kangtai Hepatitis A and B Vaccine Product Overview
9.11.3 Bio Kangtai Hepatitis A and B Vaccine Product Market Performance
9.11.4 Bio Kangtai Business Overview
9.11.5 Bio Kangtai Recent Developments
9.12 Dynavax
9.12.1 Dynavax Hepatitis A and B Vaccine Basic Information
9.12.2 Dynavax Hepatitis A and B Vaccine Product Overview
9.12.3 Dynavax Hepatitis A and B Vaccine Product Market Performance
9.12.4 Dynavax Business Overview
9.12.5 Dynavax Recent Developments
9.13 Hissen
9.13.1 Hissen Hepatitis A and B Vaccine Basic Information
9.13.2 Hissen Hepatitis A and B Vaccine Product Overview
9.13.3 Hissen Hepatitis A and B Vaccine Product Market Performance
9.13.4 Hissen Business Overview
9.13.5 Hissen Recent Developments
9.14 LG Life Sciences
9.14.1 LG Life Sciences Hepatitis A and B Vaccine Basic Information
9.14.2 LG Life Sciences Hepatitis A and B Vaccine Product Overview
9.14.3 LG Life Sciences Hepatitis A and B Vaccine Product Market Performance
9.14.4 LG Life Sciences Business Overview
9.14.5 LG Life Sciences Recent Developments
9.15 Serum Institute
9.15.1 Serum Institute Hepatitis A and B Vaccine Basic Information
9.15.2 Serum Institute Hepatitis A and B Vaccine Product Overview
9.15.3 Serum Institute Hepatitis A and B Vaccine Product Market Performance
9.15.4 Serum Institute Business Overview
9.15.5 Serum Institute Recent Developments
10 HEPATITIS A AND B VACCINE MARKET FORECAST BY REGION
10.1 Global Hepatitis A and B Vaccine Market Size Forecast
10.2 Global Hepatitis A and B Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Hepatitis A and B Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Hepatitis A and B Vaccine Market Size Forecast by Region
10.2.4 South America Hepatitis A and B Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Hepatitis A and B Vaccine by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Hepatitis A and B Vaccine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Hepatitis A and B Vaccine by Type (2025-2030)
11.1.2 Global Hepatitis A and B Vaccine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Hepatitis A and B Vaccine by Type (2025-2030)
11.2 Global Hepatitis A and B Vaccine Market Forecast by Application (2025-2030)
11.2.1 Global Hepatitis A and B Vaccine Sales (Kilotons) Forecast by Application
11.2.2 Global Hepatitis A and B Vaccine Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Hepatitis A and B Vaccine
1.2 Key Market Segments
1.2.1 Hepatitis A and B Vaccine Segment by Type
1.2.2 Hepatitis A and B Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HEPATITIS A AND B VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Hepatitis A and B Vaccine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Hepatitis A and B Vaccine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HEPATITIS A AND B VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Global Hepatitis A and B Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Hepatitis A and B Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Hepatitis A and B Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Hepatitis A and B Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Hepatitis A and B Vaccine Sales Sites, Area Served, Product Type
3.6 Hepatitis A and B Vaccine Market Competitive Situation and Trends
3.6.1 Hepatitis A and B Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Hepatitis A and B Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 HEPATITIS A AND B VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Hepatitis A and B Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HEPATITIS A AND B VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 HEPATITIS A AND B VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Hepatitis A and B Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Hepatitis A and B Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Hepatitis A and B Vaccine Price by Type (2019-2024)
7 HEPATITIS A AND B VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Hepatitis A and B Vaccine Market Sales by Application (2019-2024)
7.3 Global Hepatitis A and B Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Hepatitis A and B Vaccine Sales Growth Rate by Application (2019-2024)
8 HEPATITIS A AND B VACCINE MARKET SEGMENTATION BY REGION
8.1 Global Hepatitis A and B Vaccine Sales by Region
8.1.1 Global Hepatitis A and B Vaccine Sales by Region
8.1.2 Global Hepatitis A and B Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Hepatitis A and B Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Hepatitis A and B Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Hepatitis A and B Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Hepatitis A and B Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Hepatitis A and B Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 GSK
9.1.1 GSK Hepatitis A and B Vaccine Basic Information
9.1.2 GSK Hepatitis A and B Vaccine Product Overview
9.1.3 GSK Hepatitis A and B Vaccine Product Market Performance
9.1.4 GSK Business Overview
9.1.5 GSK Hepatitis A and B Vaccine SWOT Analysis
9.1.6 GSK Recent Developments
9.2 Merck
9.2.1 Merck Hepatitis A and B Vaccine Basic Information
9.2.2 Merck Hepatitis A and B Vaccine Product Overview
9.2.3 Merck Hepatitis A and B Vaccine Product Market Performance
9.2.4 Merck Business Overview
9.2.5 Merck Hepatitis A and B Vaccine SWOT Analysis
9.2.6 Merck Recent Developments
9.3 Sanofi
9.3.1 Sanofi Hepatitis A and B Vaccine Basic Information
9.3.2 Sanofi Hepatitis A and B Vaccine Product Overview
9.3.3 Sanofi Hepatitis A and B Vaccine Product Market Performance
9.3.4 Sanofi Hepatitis A and B Vaccine SWOT Analysis
9.3.5 Sanofi Business Overview
9.3.6 Sanofi Recent Developments
9.4 Sinovac
9.4.1 Sinovac Hepatitis A and B Vaccine Basic Information
9.4.2 Sinovac Hepatitis A and B Vaccine Product Overview
9.4.3 Sinovac Hepatitis A and B Vaccine Product Market Performance
9.4.4 Sinovac Business Overview
9.4.5 Sinovac Recent Developments
9.5 Zhejiang Pukang
9.5.1 Zhejiang Pukang Hepatitis A and B Vaccine Basic Information
9.5.2 Zhejiang Pukang Hepatitis A and B Vaccine Product Overview
9.5.3 Zhejiang Pukang Hepatitis A and B Vaccine Product Market Performance
9.5.4 Zhejiang Pukang Business Overview
9.5.5 Zhejiang Pukang Recent Developments
9.6 Changchun Institute of Biological
9.6.1 Changchun Institute of Biological Hepatitis A and B Vaccine Basic Information
9.6.2 Changchun Institute of Biological Hepatitis A and B Vaccine Product Overview
9.6.3 Changchun Institute of Biological Hepatitis A and B Vaccine Product Market Performance
9.6.4 Changchun Institute of Biological Business Overview
9.6.5 Changchun Institute of Biological Recent Developments
9.7 KM Biologics
9.7.1 KM Biologics Hepatitis A and B Vaccine Basic Information
9.7.2 KM Biologics Hepatitis A and B Vaccine Product Overview
9.7.3 KM Biologics Hepatitis A and B Vaccine Product Market Performance
9.7.4 KM Biologics Business Overview
9.7.5 KM Biologics Recent Developments
9.8 IMBCAMS
9.8.1 IMBCAMS Hepatitis A and B Vaccine Basic Information
9.8.2 IMBCAMS Hepatitis A and B Vaccine Product Overview
9.8.3 IMBCAMS Hepatitis A and B Vaccine Product Market Performance
9.8.4 IMBCAMS Business Overview
9.8.5 IMBCAMS Recent Developments
9.9 Convac
9.9.1 Convac Hepatitis A and B Vaccine Basic Information
9.9.2 Convac Hepatitis A and B Vaccine Product Overview
9.9.3 Convac Hepatitis A and B Vaccine Product Market Performance
9.9.4 Convac Business Overview
9.9.5 Convac Recent Developments
9.10 NCPC
9.10.1 NCPC Hepatitis A and B Vaccine Basic Information
9.10.2 NCPC Hepatitis A and B Vaccine Product Overview
9.10.3 NCPC Hepatitis A and B Vaccine Product Market Performance
9.10.4 NCPC Business Overview
9.10.5 NCPC Recent Developments
9.11 Bio Kangtai
9.11.1 Bio Kangtai Hepatitis A and B Vaccine Basic Information
9.11.2 Bio Kangtai Hepatitis A and B Vaccine Product Overview
9.11.3 Bio Kangtai Hepatitis A and B Vaccine Product Market Performance
9.11.4 Bio Kangtai Business Overview
9.11.5 Bio Kangtai Recent Developments
9.12 Dynavax
9.12.1 Dynavax Hepatitis A and B Vaccine Basic Information
9.12.2 Dynavax Hepatitis A and B Vaccine Product Overview
9.12.3 Dynavax Hepatitis A and B Vaccine Product Market Performance
9.12.4 Dynavax Business Overview
9.12.5 Dynavax Recent Developments
9.13 Hissen
9.13.1 Hissen Hepatitis A and B Vaccine Basic Information
9.13.2 Hissen Hepatitis A and B Vaccine Product Overview
9.13.3 Hissen Hepatitis A and B Vaccine Product Market Performance
9.13.4 Hissen Business Overview
9.13.5 Hissen Recent Developments
9.14 LG Life Sciences
9.14.1 LG Life Sciences Hepatitis A and B Vaccine Basic Information
9.14.2 LG Life Sciences Hepatitis A and B Vaccine Product Overview
9.14.3 LG Life Sciences Hepatitis A and B Vaccine Product Market Performance
9.14.4 LG Life Sciences Business Overview
9.14.5 LG Life Sciences Recent Developments
9.15 Serum Institute
9.15.1 Serum Institute Hepatitis A and B Vaccine Basic Information
9.15.2 Serum Institute Hepatitis A and B Vaccine Product Overview
9.15.3 Serum Institute Hepatitis A and B Vaccine Product Market Performance
9.15.4 Serum Institute Business Overview
9.15.5 Serum Institute Recent Developments
10 HEPATITIS A AND B VACCINE MARKET FORECAST BY REGION
10.1 Global Hepatitis A and B Vaccine Market Size Forecast
10.2 Global Hepatitis A and B Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Hepatitis A and B Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Hepatitis A and B Vaccine Market Size Forecast by Region
10.2.4 South America Hepatitis A and B Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Hepatitis A and B Vaccine by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Hepatitis A and B Vaccine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Hepatitis A and B Vaccine by Type (2025-2030)
11.1.2 Global Hepatitis A and B Vaccine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Hepatitis A and B Vaccine by Type (2025-2030)
11.2 Global Hepatitis A and B Vaccine Market Forecast by Application (2025-2030)
11.2.1 Global Hepatitis A and B Vaccine Sales (Kilotons) Forecast by Application
11.2.2 Global Hepatitis A and B Vaccine Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Hepatitis A and B Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Hepatitis A and B Vaccine Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Hepatitis A and B Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Hepatitis A and B Vaccine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Hepatitis A and B Vaccine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis A and B Vaccine as of 2022)
Table 10. Global Market Hepatitis A and B Vaccine Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Hepatitis A and B Vaccine Sales Sites and Area Served
Table 12. Manufacturers Hepatitis A and B Vaccine Product Type
Table 13. Global Hepatitis A and B Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Hepatitis A and B Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Hepatitis A and B Vaccine Market Challenges
Table 22. Global Hepatitis A and B Vaccine Sales by Type (Kilotons)
Table 23. Global Hepatitis A and B Vaccine Market Size by Type (M USD)
Table 24. Global Hepatitis A and B Vaccine Sales (Kilotons) by Type (2019-2024)
Table 25. Global Hepatitis A and B Vaccine Sales Market Share by Type (2019-2024)
Table 26. Global Hepatitis A and B Vaccine Market Size (M USD) by Type (2019-2024)
Table 27. Global Hepatitis A and B Vaccine Market Size Share by Type (2019-2024)
Table 28. Global Hepatitis A and B Vaccine Price (USD/Ton) by Type (2019-2024)
Table 29. Global Hepatitis A and B Vaccine Sales (Kilotons) by Application
Table 30. Global Hepatitis A and B Vaccine Market Size by Application
Table 31. Global Hepatitis A and B Vaccine Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Hepatitis A and B Vaccine Sales Market Share by Application (2019-2024)
Table 33. Global Hepatitis A and B Vaccine Sales by Application (2019-2024) & (M USD)
Table 34. Global Hepatitis A and B Vaccine Market Share by Application (2019-2024)
Table 35. Global Hepatitis A and B Vaccine Sales Growth Rate by Application (2019-2024)
Table 36. Global Hepatitis A and B Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Hepatitis A and B Vaccine Sales Market Share by Region (2019-2024)
Table 38. North America Hepatitis A and B Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Hepatitis A and B Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Hepatitis A and B Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Hepatitis A and B Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Hepatitis A and B Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 43. GSK Hepatitis A and B Vaccine Basic Information
Table 44. GSK Hepatitis A and B Vaccine Product Overview
Table 45. GSK Hepatitis A and B Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. GSK Business Overview
Table 47. GSK Hepatitis A and B Vaccine SWOT Analysis
Table 48. GSK Recent Developments
Table 49. Merck Hepatitis A and B Vaccine Basic Information
Table 50. Merck Hepatitis A and B Vaccine Product Overview
Table 51. Merck Hepatitis A and B Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Merck Business Overview
Table 53. Merck Hepatitis A and B Vaccine SWOT Analysis
Table 54. Merck Recent Developments
Table 55. Sanofi Hepatitis A and B Vaccine Basic Information
Table 56. Sanofi Hepatitis A and B Vaccine Product Overview
Table 57. Sanofi Hepatitis A and B Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Sanofi Hepatitis A and B Vaccine SWOT Analysis
Table 59. Sanofi Business Overview
Table 60. Sanofi Recent Developments
Table 61. Sinovac Hepatitis A and B Vaccine Basic Information
Table 62. Sinovac Hepatitis A and B Vaccine Product Overview
Table 63. Sinovac Hepatitis A and B Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Sinovac Business Overview
Table 65. Sinovac Recent Developments
Table 66. Zhejiang Pukang Hepatitis A and B Vaccine Basic Information
Table 67. Zhejiang Pukang Hepatitis A and B Vaccine Product Overview
Table 68. Zhejiang Pukang Hepatitis A and B Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Zhejiang Pukang Business Overview
Table 70. Zhejiang Pukang Recent Developments
Table 71. Changchun Institute of Biological Hepatitis A and B Vaccine Basic Information
Table 72. Changchun Institute of Biological Hepatitis A and B Vaccine Product Overview
Table 73. Changchun Institute of Biological Hepatitis A and B Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Changchun Institute of Biological Business Overview
Table 75. Changchun Institute of Biological Recent Developments
Table 76. KM Biologics Hepatitis A and B Vaccine Basic Information
Table 77. KM Biologics Hepatitis A and B Vaccine Product Overview
Table 78. KM Biologics Hepatitis A and B Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. KM Biologics Business Overview
Table 80. KM Biologics Recent Developments
Table 81. IMBCAMS Hepatitis A and B Vaccine Basic Information
Table 82. IMBCAMS Hepatitis A and B Vaccine Product Overview
Table 83. IMBCAMS Hepatitis A and B Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. IMBCAMS Business Overview
Table 85. IMBCAMS Recent Developments
Table 86. Convac Hepatitis A and B Vaccine Basic Information
Table 87. Convac Hepatitis A and B Vaccine Product Overview
Table 88. Convac Hepatitis A and B Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Convac Business Overview
Table 90. Convac Recent Developments
Table 91. NCPC Hepatitis A and B Vaccine Basic Information
Table 92. NCPC Hepatitis A and B Vaccine Product Overview
Table 93. NCPC Hepatitis A and B Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. NCPC Business Overview
Table 95. NCPC Recent Developments
Table 96. Bio Kangtai Hepatitis A and B Vaccine Basic Information
Table 97. Bio Kangtai Hepatitis A and B Vaccine Product Overview
Table 98. Bio Kangtai Hepatitis A and B Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Bio Kangtai Business Overview
Table 100. Bio Kangtai Recent Developments
Table 101. Dynavax Hepatitis A and B Vaccine Basic Information
Table 102. Dynavax Hepatitis A and B Vaccine Product Overview
Table 103. Dynavax Hepatitis A and B Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Dynavax Business Overview
Table 105. Dynavax Recent Developments
Table 106. Hissen Hepatitis A and B Vaccine Basic Information
Table 107. Hissen Hepatitis A and B Vaccine Product Overview
Table 108. Hissen Hepatitis A and B Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Hissen Business Overview
Table 110. Hissen Recent Developments
Table 111. LG Life Sciences Hepatitis A and B Vaccine Basic Information
Table 112. LG Life Sciences Hepatitis A and B Vaccine Product Overview
Table 113. LG Life Sciences Hepatitis A and B Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. LG Life Sciences Business Overview
Table 115. LG Life Sciences Recent Developments
Table 116. Serum Institute Hepatitis A and B Vaccine Basic Information
Table 117. Serum Institute Hepatitis A and B Vaccine Product Overview
Table 118. Serum Institute Hepatitis A and B Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Serum Institute Business Overview
Table 120. Serum Institute Recent Developments
Table 121. Global Hepatitis A and B Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 122. Global Hepatitis A and B Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 123. North America Hepatitis A and B Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 124. North America Hepatitis A and B Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 125. Europe Hepatitis A and B Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 126. Europe Hepatitis A and B Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 127. Asia Pacific Hepatitis A and B Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 128. Asia Pacific Hepatitis A and B Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 129. South America Hepatitis A and B Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 130. South America Hepatitis A and B Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 131. Middle East and Africa Hepatitis A and B Vaccine Consumption Forecast by Country (2025-2030) & (Units)
Table 132. Middle East and Africa Hepatitis A and B Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 133. Global Hepatitis A and B Vaccine Sales Forecast by Type (2025-2030) & (Kilotons)
Table 134. Global Hepatitis A and B Vaccine Market Size Forecast by Type (2025-2030) & (M USD)
Table 135. Global Hepatitis A and B Vaccine Price Forecast by Type (2025-2030) & (USD/Ton)
Table 136. Global Hepatitis A and B Vaccine Sales (Kilotons) Forecast by Application (2025-2030)
Table 137. Global Hepatitis A and B Vaccine Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Hepatitis A and B Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Hepatitis A and B Vaccine Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Hepatitis A and B Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Hepatitis A and B Vaccine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Hepatitis A and B Vaccine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis A and B Vaccine as of 2022)
Table 10. Global Market Hepatitis A and B Vaccine Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Hepatitis A and B Vaccine Sales Sites and Area Served
Table 12. Manufacturers Hepatitis A and B Vaccine Product Type
Table 13. Global Hepatitis A and B Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Hepatitis A and B Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Hepatitis A and B Vaccine Market Challenges
Table 22. Global Hepatitis A and B Vaccine Sales by Type (Kilotons)
Table 23. Global Hepatitis A and B Vaccine Market Size by Type (M USD)
Table 24. Global Hepatitis A and B Vaccine Sales (Kilotons) by Type (2019-2024)
Table 25. Global Hepatitis A and B Vaccine Sales Market Share by Type (2019-2024)
Table 26. Global Hepatitis A and B Vaccine Market Size (M USD) by Type (2019-2024)
Table 27. Global Hepatitis A and B Vaccine Market Size Share by Type (2019-2024)
Table 28. Global Hepatitis A and B Vaccine Price (USD/Ton) by Type (2019-2024)
Table 29. Global Hepatitis A and B Vaccine Sales (Kilotons) by Application
Table 30. Global Hepatitis A and B Vaccine Market Size by Application
Table 31. Global Hepatitis A and B Vaccine Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Hepatitis A and B Vaccine Sales Market Share by Application (2019-2024)
Table 33. Global Hepatitis A and B Vaccine Sales by Application (2019-2024) & (M USD)
Table 34. Global Hepatitis A and B Vaccine Market Share by Application (2019-2024)
Table 35. Global Hepatitis A and B Vaccine Sales Growth Rate by Application (2019-2024)
Table 36. Global Hepatitis A and B Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Hepatitis A and B Vaccine Sales Market Share by Region (2019-2024)
Table 38. North America Hepatitis A and B Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Hepatitis A and B Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Hepatitis A and B Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Hepatitis A and B Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Hepatitis A and B Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 43. GSK Hepatitis A and B Vaccine Basic Information
Table 44. GSK Hepatitis A and B Vaccine Product Overview
Table 45. GSK Hepatitis A and B Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. GSK Business Overview
Table 47. GSK Hepatitis A and B Vaccine SWOT Analysis
Table 48. GSK Recent Developments
Table 49. Merck Hepatitis A and B Vaccine Basic Information
Table 50. Merck Hepatitis A and B Vaccine Product Overview
Table 51. Merck Hepatitis A and B Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Merck Business Overview
Table 53. Merck Hepatitis A and B Vaccine SWOT Analysis
Table 54. Merck Recent Developments
Table 55. Sanofi Hepatitis A and B Vaccine Basic Information
Table 56. Sanofi Hepatitis A and B Vaccine Product Overview
Table 57. Sanofi Hepatitis A and B Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Sanofi Hepatitis A and B Vaccine SWOT Analysis
Table 59. Sanofi Business Overview
Table 60. Sanofi Recent Developments
Table 61. Sinovac Hepatitis A and B Vaccine Basic Information
Table 62. Sinovac Hepatitis A and B Vaccine Product Overview
Table 63. Sinovac Hepatitis A and B Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Sinovac Business Overview
Table 65. Sinovac Recent Developments
Table 66. Zhejiang Pukang Hepatitis A and B Vaccine Basic Information
Table 67. Zhejiang Pukang Hepatitis A and B Vaccine Product Overview
Table 68. Zhejiang Pukang Hepatitis A and B Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Zhejiang Pukang Business Overview
Table 70. Zhejiang Pukang Recent Developments
Table 71. Changchun Institute of Biological Hepatitis A and B Vaccine Basic Information
Table 72. Changchun Institute of Biological Hepatitis A and B Vaccine Product Overview
Table 73. Changchun Institute of Biological Hepatitis A and B Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Changchun Institute of Biological Business Overview
Table 75. Changchun Institute of Biological Recent Developments
Table 76. KM Biologics Hepatitis A and B Vaccine Basic Information
Table 77. KM Biologics Hepatitis A and B Vaccine Product Overview
Table 78. KM Biologics Hepatitis A and B Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. KM Biologics Business Overview
Table 80. KM Biologics Recent Developments
Table 81. IMBCAMS Hepatitis A and B Vaccine Basic Information
Table 82. IMBCAMS Hepatitis A and B Vaccine Product Overview
Table 83. IMBCAMS Hepatitis A and B Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. IMBCAMS Business Overview
Table 85. IMBCAMS Recent Developments
Table 86. Convac Hepatitis A and B Vaccine Basic Information
Table 87. Convac Hepatitis A and B Vaccine Product Overview
Table 88. Convac Hepatitis A and B Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Convac Business Overview
Table 90. Convac Recent Developments
Table 91. NCPC Hepatitis A and B Vaccine Basic Information
Table 92. NCPC Hepatitis A and B Vaccine Product Overview
Table 93. NCPC Hepatitis A and B Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. NCPC Business Overview
Table 95. NCPC Recent Developments
Table 96. Bio Kangtai Hepatitis A and B Vaccine Basic Information
Table 97. Bio Kangtai Hepatitis A and B Vaccine Product Overview
Table 98. Bio Kangtai Hepatitis A and B Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Bio Kangtai Business Overview
Table 100. Bio Kangtai Recent Developments
Table 101. Dynavax Hepatitis A and B Vaccine Basic Information
Table 102. Dynavax Hepatitis A and B Vaccine Product Overview
Table 103. Dynavax Hepatitis A and B Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Dynavax Business Overview
Table 105. Dynavax Recent Developments
Table 106. Hissen Hepatitis A and B Vaccine Basic Information
Table 107. Hissen Hepatitis A and B Vaccine Product Overview
Table 108. Hissen Hepatitis A and B Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Hissen Business Overview
Table 110. Hissen Recent Developments
Table 111. LG Life Sciences Hepatitis A and B Vaccine Basic Information
Table 112. LG Life Sciences Hepatitis A and B Vaccine Product Overview
Table 113. LG Life Sciences Hepatitis A and B Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. LG Life Sciences Business Overview
Table 115. LG Life Sciences Recent Developments
Table 116. Serum Institute Hepatitis A and B Vaccine Basic Information
Table 117. Serum Institute Hepatitis A and B Vaccine Product Overview
Table 118. Serum Institute Hepatitis A and B Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Serum Institute Business Overview
Table 120. Serum Institute Recent Developments
Table 121. Global Hepatitis A and B Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 122. Global Hepatitis A and B Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 123. North America Hepatitis A and B Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 124. North America Hepatitis A and B Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 125. Europe Hepatitis A and B Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 126. Europe Hepatitis A and B Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 127. Asia Pacific Hepatitis A and B Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 128. Asia Pacific Hepatitis A and B Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 129. South America Hepatitis A and B Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 130. South America Hepatitis A and B Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 131. Middle East and Africa Hepatitis A and B Vaccine Consumption Forecast by Country (2025-2030) & (Units)
Table 132. Middle East and Africa Hepatitis A and B Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 133. Global Hepatitis A and B Vaccine Sales Forecast by Type (2025-2030) & (Kilotons)
Table 134. Global Hepatitis A and B Vaccine Market Size Forecast by Type (2025-2030) & (M USD)
Table 135. Global Hepatitis A and B Vaccine Price Forecast by Type (2025-2030) & (USD/Ton)
Table 136. Global Hepatitis A and B Vaccine Sales (Kilotons) Forecast by Application (2025-2030)
Table 137. Global Hepatitis A and B Vaccine Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Hepatitis A and B Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Hepatitis A and B Vaccine Market Size (M USD), 2019-2030
Figure 5. Global Hepatitis A and B Vaccine Market Size (M USD) (2019-2030)
Figure 6. Global Hepatitis A and B Vaccine Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Hepatitis A and B Vaccine Market Size by Country (M USD)
Figure 11. Hepatitis A and B Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Hepatitis A and B Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Hepatitis A and B Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Hepatitis A and B Vaccine Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Hepatitis A and B Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Hepatitis A and B Vaccine Market Share by Type
Figure 18. Sales Market Share of Hepatitis A and B Vaccine by Type (2019-2024)
Figure 19. Sales Market Share of Hepatitis A and B Vaccine by Type in 2023
Figure 20. Market Size Share of Hepatitis A and B Vaccine by Type (2019-2024)
Figure 21. Market Size Market Share of Hepatitis A and B Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Hepatitis A and B Vaccine Market Share by Application
Figure 24. Global Hepatitis A and B Vaccine Sales Market Share by Application (2019-2024)
Figure 25. Global Hepatitis A and B Vaccine Sales Market Share by Application in 2023
Figure 26. Global Hepatitis A and B Vaccine Market Share by Application (2019-2024)
Figure 27. Global Hepatitis A and B Vaccine Market Share by Application in 2023
Figure 28. Global Hepatitis A and B Vaccine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Hepatitis A and B Vaccine Sales Market Share by Region (2019-2024)
Figure 30. North America Hepatitis A and B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Hepatitis A and B Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Hepatitis A and B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Hepatitis A and B Vaccine Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Hepatitis A and B Vaccine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Hepatitis A and B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Hepatitis A and B Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Hepatitis A and B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Hepatitis A and B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Hepatitis A and B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Hepatitis A and B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Hepatitis A and B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Hepatitis A and B Vaccine Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Hepatitis A and B Vaccine Sales Market Share by Region in 2023
Figure 44. China Hepatitis A and B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Hepatitis A and B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Hepatitis A and B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Hepatitis A and B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Hepatitis A and B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Hepatitis A and B Vaccine Sales and Growth Rate (Kilotons)
Figure 50. South America Hepatitis A and B Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Hepatitis A and B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Hepatitis A and B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Hepatitis A and B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Hepatitis A and B Vaccine Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Hepatitis A and B Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Hepatitis A and B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Hepatitis A and B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Hepatitis A and B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Hepatitis A and B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Hepatitis A and B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Hepatitis A and B Vaccine Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Hepatitis A and B Vaccine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Hepatitis A and B Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Hepatitis A and B Vaccine Market Share Forecast by Type (2025-2030)
Figure 65. Global Hepatitis A and B Vaccine Sales Forecast by Application (2025-2030)
Figure 66. Global Hepatitis A and B Vaccine Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Hepatitis A and B Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Hepatitis A and B Vaccine Market Size (M USD), 2019-2030
Figure 5. Global Hepatitis A and B Vaccine Market Size (M USD) (2019-2030)
Figure 6. Global Hepatitis A and B Vaccine Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Hepatitis A and B Vaccine Market Size by Country (M USD)
Figure 11. Hepatitis A and B Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Hepatitis A and B Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Hepatitis A and B Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Hepatitis A and B Vaccine Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Hepatitis A and B Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Hepatitis A and B Vaccine Market Share by Type
Figure 18. Sales Market Share of Hepatitis A and B Vaccine by Type (2019-2024)
Figure 19. Sales Market Share of Hepatitis A and B Vaccine by Type in 2023
Figure 20. Market Size Share of Hepatitis A and B Vaccine by Type (2019-2024)
Figure 21. Market Size Market Share of Hepatitis A and B Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Hepatitis A and B Vaccine Market Share by Application
Figure 24. Global Hepatitis A and B Vaccine Sales Market Share by Application (2019-2024)
Figure 25. Global Hepatitis A and B Vaccine Sales Market Share by Application in 2023
Figure 26. Global Hepatitis A and B Vaccine Market Share by Application (2019-2024)
Figure 27. Global Hepatitis A and B Vaccine Market Share by Application in 2023
Figure 28. Global Hepatitis A and B Vaccine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Hepatitis A and B Vaccine Sales Market Share by Region (2019-2024)
Figure 30. North America Hepatitis A and B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Hepatitis A and B Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Hepatitis A and B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Hepatitis A and B Vaccine Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Hepatitis A and B Vaccine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Hepatitis A and B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Hepatitis A and B Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Hepatitis A and B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Hepatitis A and B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Hepatitis A and B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Hepatitis A and B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Hepatitis A and B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Hepatitis A and B Vaccine Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Hepatitis A and B Vaccine Sales Market Share by Region in 2023
Figure 44. China Hepatitis A and B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Hepatitis A and B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Hepatitis A and B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Hepatitis A and B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Hepatitis A and B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Hepatitis A and B Vaccine Sales and Growth Rate (Kilotons)
Figure 50. South America Hepatitis A and B Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Hepatitis A and B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Hepatitis A and B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Hepatitis A and B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Hepatitis A and B Vaccine Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Hepatitis A and B Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Hepatitis A and B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Hepatitis A and B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Hepatitis A and B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Hepatitis A and B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Hepatitis A and B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Hepatitis A and B Vaccine Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Hepatitis A and B Vaccine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Hepatitis A and B Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Hepatitis A and B Vaccine Market Share Forecast by Type (2025-2030)
Figure 65. Global Hepatitis A and B Vaccine Sales Forecast by Application (2025-2030)
Figure 66. Global Hepatitis A and B Vaccine Market Share Forecast by Application (2025-2030)
